• Low Risk for IBD Relapse After Switch From IV to Subcutaneous Infliximab

    3 monthes ago - By MedPageToday

    Switching from intravenous to subcutaneous infliximab was safe and effective for patients with inflammatory bowel disease in clinical remission, an observational study in France showed.
    Among 133 patients treated...
    Read more ...

     

  • Disease recurrence linked to cessation of DMTs in patients with relapsing-remitting MS

    Disease recurrence linked to cessation of DMTs in patients with relapsing-remitting MS

    3 monthes ago - By Healio

    In patients with relapsing-remitting multiple sclerosis, disease reactivation occurred within months of cessation of disease-modifying therapy but was reduced after starting a new treatment, according to a study published in Neurology.
    “Treatment interruptions are common in patients with multiple sclerosis. Disease-modifying therapies may be stopped or switched for reasons of efficacy, tolerability, safety and preference,” Izanne Roos, PhD, of the department of neurology at Royal Melbourne Hospital in Australia, and colleagues wrote. “Treatment interruptions leave
    Read more ...